Precision Medicine

Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Thumbnail

AHIMA: Patient matching a significant problem

More than half of health information management professionals routinely work on mitigating patient record duplicates at their organization and 73 percent of those do so weekly, according to a survey conducted by AHIMA. 

Mass. partnership to launch digital health innovation hub

Massachusetts will launch a public-private partnership designed to accelerate the competitiveness of its digital healthcare industry. 

Study: 1 in 3 working-age cancer survivors go into debt

Approximately one in three working-age cancer survivors went into debt after beating the disease, according to a recent study published in Health Affairs. In addition, three percent of those individuals filed for bankruptcy as a result of their high medical bills. 

athenahealth issues new innovation challenge

athenahealth is expanding its More Disruption Please (MDP) effort with two challenges.  

Thumbnail

Journal names top 100 digital health companies

The Journal of mHealth is making it easy to learn more about digital health and the top companies in the market. 

Thumbnail

Just 25% of doctors prepared to handle complex patients

One-quarter of U.S. physicians are not prepared to effectively manage and coordinate care for patients with multiple chronic conditions, and 84 percent are not prepared for managing care of patients with severe mental health problems, according to a Commonwealth Fund study published in Health Affairs. 

AT&T opening first innovation center devoted to healthcare

Telecommunications company AT&T is expanding its reach into the healthcare sector by establishing the AT&T Foundry for Connected Health, set to open in Houston next month, according to a Fortune report.

ECRI Institute's 2016 watch list includes device security and wearable sensors

ECRI Institute has released its annual list of the new and emerging drugs, devices, procedures and care processes most likely to impact patient care over the next 12-18 months.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.